IP Library Granted Patent US 9,745,616
Granted Patent B2
US 9,745,616 · App. 14/118,524 · Granted Aug 29, 2017

Methods and compositions for detecting target nucleic acids

Inventors: Robert Terbrueggen (Manhattan Beach, CA); Yenbou Liu (Arcadia, CA); John Ray Childers, Jr. (Long Beach, CA); Chang Hee Kim (Rancho Palos Verdes, CA); Majid R. Abedi (Anaheim, CA)
Assignee: DXTERITY DIAGNOSTICS INCORPORATED
C12Q1/6813C12Q1/6809C12Q1/6834C12Q1/6855C12Q1/6862
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,745,616
App. No.
14/118,524
Granted
Aug 29, 2017
Kind
B2
Abstract

The present invention provides compositions, apparatuses and methods for detecting one or more nucleic acid targets present in a sample. Methods of the invention include utilizing two or more ligation probes that reversibly bind a target nucleic acid in close proximity to each other and possess complementary reactive ligation moieties. When such probes have bound to the target in the proper orientation, they are able to undergo a spontaneous chemical ligation reaction that yields a ligation product that is directly detected or that is amplified to produce amplicons that are then detected. The present invention also provides methods to stabilize sample RNA so that degradation does not significantly affect the results of the analysis.

Claims (40)

1. A method for detecting a plurality of different target nucleic acids in a sample, wherein each target nucleic acid comprises a first target domain adjacent to a second target domain and a third target capture domain located upstream or downstream from said first and second target domains, said method comprising:

(a) providing a plurality of ligation substrates each comprising:

(i) one of said target nucleic acids;

(ii) a first set of ligation probes comprising:

(A) a first nucleic acid ligation probe comprising:

(1) a first probe domain hybridized to a first target domain of said one target nucleic acid sequence;

(2) a 5′-ligation moiety; and

(B) a second nucleic acid ligation probe comprising:

(1) a second probe domain hybridized to a second target domain of said one target nucleic acid sequence; and

(2) a 3′ ligation moiety;

(b) ligating said first and second ligation probes without the use of a ligase enzyme to form a first plurality of ligation products;

(c) hybridizing target capture probes comprising a capture moiety to said third target domain of said target nucleic acids to form target complexes;

(d) capturing said target complexes on a surface using said capture moiety;

(e) amplifying said ligation products to form amplicons;

(f) detecting said amplicons,

thereby detecting said target nucleic acids.

2. The method of claim 1 , wherein:

said target nucleic acids further comprise a fourth target domain adjacent to a fifth target domain;

said plurality of ligation substrates each further comprises a second set of ligation probes comprising a third nucleic acid ligation probe hybridized to said fourth target domain and a fourth nucleic acid ligation probe hybridized to said fifth target domain;

said method further comprising ligating said third and fourth ligation probes in the absence of a ligase enzyme such that said one target nucleic acid sequence comprises multiple ligation products;

and said detecting step (f) comprises detecting amplicons generated from said multiple ligation products.

3. The method of claim 2 , wherein said target nucleic acids further comprise a sixth target domain adjacent to a seventh target domain;

said plurality of ligation substrates each further comprises a third set of ligation probes comprising a fifth nucleic acid ligation probe hybridized to said sixth target domain and a sixth nucleic acid ligation probe hybridized to said seventh target domain;

said method further comprising ligating said third and fourth ligation probes in the absence of a ligase enzyme such that said one target nucleic acid sequence comprises multiple ligation products.

4. The method of claim 1 , wherein each of said ligation probes further comprises a primer sequence.

5. The method of claim 1 , wherein at least one of said ligation probes of each set of ligation probes further comprise a variable spacer sequence such that said amplicons have a target specific length.

6. The method of claim 1 , wherein only one ligation probe of each set of ligation probes comprises said variable spacer sequence.

7. The method of claim 5 , wherein said variable spacer sequence is contained between said probe domain and said primer of said ligation probe.

8. The method of claim 1 , wherein said capture moiety of said target capture probe comprises a member selected from: a capture nucleic acid sequence, a bead and a binding partner of a binding partner pair.

9. The method of claim 1 , wherein said 5′ ligation moiety comprises DABSYL and said 3′ ligation moiety comprises phosphorothioate.

10. The method of claim 1 , wherein said 3′ ligation moiety comprises DABSYL.

11. The method of claim 1 , wherein said sample was collected into a buffer comprising guanidinium hydrochloride (GuHCl).

12. The method of claim 11 , wherein said sample is blood.

13. The method of claim 1 , wherein said target nucleic acids comprise RNA.

14. The method of claim 1 , wherein said detecting step (f) utilizes a technique selected from the group consisting of capillary electrophoresis, mass spectrometry, microarray analysis, sequencing, real-time PCR, optical detection, fluorescence detection, bioluminescence detection, chemiluminescence detection, electrochemical detection, electrochemiluminescence detection and lateral flow detection.

15. The method of claim 1 , wherein said hybridizing step (c) occurs simultaneously with said ligating step (b).

16. A method for detecting a plurality of target RNA sequences in a sample, wherein each target nucleic acid sequence comprises an adjacent first and second target domain and a third target domain, said method comprising:

(a) collecting a sample into a buffer to form a stabilized sample;

(b) conducting an assay in accordance with claim 1 in said stabilized sample to detect said plurality of target nucleic acids.

17. The method of claim 16 , wherein said sample is stable for at least 1 week at ambient room temperature.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2015
From: SILICON VALLEY BANK
To: DXTERITY DIAGNOSTICS
Reel/Frame 035438/0992 →
SECURITY INTEREST Recorded Apr 17, 2015
From: DXTERITY DIAGNOSTICS INCORPORATED
To: SWK FUNDING LLC
Reel/Frame 035439/0279 →
SECURITY INTEREST Recorded Sep 30, 2014
From: DXTERITY DIAGNOSTICS INCORPORATED
To: SILICON VALLEY BANK
Reel/Frame 033845/0051 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2014
From: TERBRUEGGEN, ROBERT; LIU, YENBOU; CHILDERS, JOHN RAY, JR.; KIM, CHANG HEE; ABEDI, MAJID R.
To: DXTERITY DIAGNOSTICS INCORPORATED
Reel/Frame 032358/0580 →
Continuity (2)
Provisional Application 61486817 · May 17, 2011
Related Publication 20140171338A1 · Jun 19, 2014